Migraine Not all headaches are migraines, and the headache side effect documented in GLP-1 clinical trials is not the same as migraine disease
Anderson Cancer Center, Houston, TX, 2007 - 2008 Department Chair, Thoracic and Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, 2007 - 2014 APN/PA Departmental Liaison, Thoracic and Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, 2003 - 2007 Director, Esophageal Cancer Program, Thoracic and Cardiovascular Surgery, The University of Texas M
Below-Label Microdosing FDA-approved medications already use gradual initiation and dose escalation to help patients adjust to treatment
Step 3: Timing is key
However, post-marketing surveillance and case reports have documented isolated instances of gastrointestinal inflammatory conditions in patients taking GLP-1 receptor agonists, including semaglutide